RLAY

Relay Therapeutics, Inc.

Healthcare · Biotechnology

$288.98 sample

-1.91 (-0.66%) 1D

Market cap

$711.2B

Price as of

2026-10-15

Latest filing

8-K · 2026-09-23

Alerts

8

Price$288.98 +12.28% 3M daily closessample

290.89255.63

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 13INSInsider sell: General Counsel
Oct 07INSInsider sell: EVP, Operations
Oct 01INSInsider sell: EVP, Operations
Sep 23SECForm 144 filed
Sep 15INSInsider sell: General Counsel
Sep 10INSInsider sell: Chief Financial Officer
Sep 04INSInsider buy: Chief Executive Officer
Sep 01INSInsider sell: EVP, Operations

Sign up to see the real RLAY record →

Company facts

SEC EDGAR registration

Name: Relay Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -46sample, -100 to +100
Reporting currency: USD

Who is positioning in RLAY

sample

Insiders: 8 insider transactions over 90 days, net selling, $335.5M
Congress: No member trades over 90 days
Institutions · 13F: 34 funds hold $17.6B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$47.7B +19.6% y/y

Q4 2024Q3 2026

Inventory$26.7B +11.2% y/y

Q4 2024Q3 2026

Accounts receivable$21.0B +9.2% y/y

Q4 2024Q3 2026

Total debt$57.0B +15.3% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $203.9B +15.8% 3M
Sample peer B: $91.8B +9.8% 3M
Sample peer C: $702.5B +9.3% 3M
Sample peer D: $597.8B -4.8% 3M
Sample peer E: $227.8B -8.2% 3M